
X
Amarin hit hard as generics loom for fish oil drug Vascepa
https://pharmaphorum.com/news/amarin-hit-hard-as-generics-loom-for-fish-oil-drug-vascepa/
Hikma to give up date in Q1 next year.
FDA rejects Hikma drug, regulator has “major” issue with Mylan’s rival.
Firms extend existing respiratory deal.
Profits hit as drug approvals delayed.